Search research articles
Contact Us
Filters
Showing results (41-50 of 83) with videos related to
Page
of 9
Sort By:
Oncotarget
|
May 17, 2018
Signature program: a platform of basket trials
Eric D Slosberg, Barinder P Kang, Julio Peguero, et al.
British Journal of Cancer
|
July 20, 2023
Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-expansion stage of a multicentre, open-label, phase I trial
Michael Friedlander, Linda Mileshkin, Janine Lombard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2021
Phase I, First-in-Human Study of the Probody Therapeutic CX-2029 in Adults with Advanced Solid Tumor Malignancies
Melissa Johnson, Anthony El-Khoueiry, Navid Hafez, et al.
Investigational New Drugs
|
February 12, 2022
Phase I trial of ATM inhibitor M3541 in combination with palliative radiotherapy in patients with solid tumors
Saiama N Waqar, Clifford Robinson, Anthony J Olszanski, et al.
Cancer Genetics and Cytogenetics
|
September 13, 2006
Dicentric (17;20)(p11.2;q11.2): an uncommon cytogenetic abnormality in myeloid malignancies
Carlos A Tirado, Aurelia M Meloni-Ehrig, Eian Wallenhorst, et al.
Clinical Colorectal Cancer
|
January 7, 2011
Phase I trial of oxaliplatin, infusional 5-fluorouracil, and leucovorin (FOLFOX4) with erlotinib and bevacizumab in colorectal cancer
Wells A Messersmith, Antonio Jimeno, Heather Jacene, et al.
Clinical Colorectal Cancer
|
April 28, 2016
A Randomized, Phase II Trial of Cetuximab With or Without PX-866, an Irreversible Oral Phosphatidylinositol 3-Kinase Inhibitor, in Patients With Metastatic Colorectal Carcinoma
Daniel W Bowles, Mark Kochenderfer, Allen Cohn, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 5, 2025
US expert Delphi consensus on the prevention and management of stomatitis in patients treated with datopotamab deruxtecan
Hope Rugo, Aditya Bardia, Debora S Bruno, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 29, 2017
A Phase I, Dose Escalation Study of Oral ASP8273 in Patients with Non-small Cell Lung Cancers with Epidermal Growth Factor Receptor Mutations
Helena A Yu, Alexander Spira, Leora Horn, et al.
Leukemia Research
|
June 11, 2020
Camidanlumab tesirine, an antibody-drug conjugate, in relapsed/refractory CD25-positive acute myeloid leukemia or acute lymphoblastic leukemia: A phase I study
Aaron D Goldberg, Ehab Atallah, David Rizzieri, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 83) with videos related to
Sort By:
Page
of 9
Oncotarget
|
May 17, 2018
Signature program: a platform of basket trials
Eric D Slosberg, Barinder P Kang, Julio Peguero, et al.
British Journal of Cancer
|
July 20, 2023
Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-expansion stage of a multicentre, open-label, phase I trial
Michael Friedlander, Linda Mileshkin, Janine Lombard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2021
Phase I, First-in-Human Study of the Probody Therapeutic CX-2029 in Adults with Advanced Solid Tumor Malignancies
Melissa Johnson, Anthony El-Khoueiry, Navid Hafez, et al.
Investigational New Drugs
|
February 12, 2022
Phase I trial of ATM inhibitor M3541 in combination with palliative radiotherapy in patients with solid tumors
Saiama N Waqar, Clifford Robinson, Anthony J Olszanski, et al.
Cancer Genetics and Cytogenetics
|
September 13, 2006
Dicentric (17;20)(p11.2;q11.2): an uncommon cytogenetic abnormality in myeloid malignancies
Carlos A Tirado, Aurelia M Meloni-Ehrig, Eian Wallenhorst, et al.
Clinical Colorectal Cancer
|
January 7, 2011
Phase I trial of oxaliplatin, infusional 5-fluorouracil, and leucovorin (FOLFOX4) with erlotinib and bevacizumab in colorectal cancer
Wells A Messersmith, Antonio Jimeno, Heather Jacene, et al.
Clinical Colorectal Cancer
|
April 28, 2016
A Randomized, Phase II Trial of Cetuximab With or Without PX-866, an Irreversible Oral Phosphatidylinositol 3-Kinase Inhibitor, in Patients With Metastatic Colorectal Carcinoma
Daniel W Bowles, Mark Kochenderfer, Allen Cohn, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 5, 2025
US expert Delphi consensus on the prevention and management of stomatitis in patients treated with datopotamab deruxtecan
Hope Rugo, Aditya Bardia, Debora S Bruno, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 29, 2017
A Phase I, Dose Escalation Study of Oral ASP8273 in Patients with Non-small Cell Lung Cancers with Epidermal Growth Factor Receptor Mutations
Helena A Yu, Alexander Spira, Leora Horn, et al.
Leukemia Research
|
June 11, 2020
Camidanlumab tesirine, an antibody-drug conjugate, in relapsed/refractory CD25-positive acute myeloid leukemia or acute lymphoblastic leukemia: A phase I study
Aaron D Goldberg, Ehab Atallah, David Rizzieri, et al.
Page
of 9